General discussion, page-19770

This is a slow burn and many are hurting here.

Bio-tech is very expensive to run........We are looking at big numbers for our trials and that equals money and patience.

Nobody spitting the dummy from our executive team................only impatient holders

Gone are the days where SH comms was supreme...............now we will only get what the company is required by the regulators to give

Good luck with all the bitching and moaning...............it really does not help anyone's cause